Dr. Jeffrey Carson is the Provost, New Brunswick at Rutgers Biomedical and Health Sciences and served as Chief of the Division of General Internal Medicine until 2015. He is currently the Distinguished Professor of Medicine and Richard C. Reynolds, M.D. Chair in General Internal Medicine.
Dr. Carson’s expertise in clinical trials has been recognized by his appointment to Clinical Trials Review Committee at the National Heart, Lung and Blood Institutes where he served as Chair during his fifth year. He has served as a member and chair of multiple clinical trial Data Safety Monitoring Boards.
The focus of Dr. Carson’s research is on determining the risk of anemia and indications for blood transfusion. His current work includes National Heart, Lung and Blood Institutes supported trials in transfusion in patients with myocardial infarction (MINT Trial; http://www.minttrial.org/), plasma use and blood utilization in China. Dr. Carson is a leader in Clinical Guidelines on Red Blood Cell Transfusion, systematic review and meta-analysis evaluating red blood cell transfusions, and author of chapter on red blood cell transfusion in the online textbook UpToDate. He recently published invited review on red cell transfusion in the New England Journal of Medicine.